Works matching DE "DRUG therapy for sickle cell anemia"
Results: 118
Menstruation and Sickle Cell Disease: Ease Her Pain.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1219, doi. 10.1007/s00228-023-03514-3
- By:
- Publication type:
- Article
Drug development: A complicated path.
- Published in:
- Nature, 2014, v. 515, n. 7526, p. S4, doi. 10.1038/515S4a
- By:
- Publication type:
- Article
Diminishing bias in sickle cell disease.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso‐occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
- Published in:
- Pain Practice, 2018, v. 18, n. 6, p. 788, doi. 10.1111/papr.12674
- By:
- Publication type:
- Article
Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 2, p. 173, doi. 10.1111/j.1365-2710.2011.01276.x
- By:
- Publication type:
- Article
Mechanisms underlying the adaptive pulp and jaw bone trabecular changes in sickle cell anemia.
- Published in:
- Oral Diseases, 2023, v. 29, n. 2, p. 786, doi. 10.1111/odi.13998
- By:
- Publication type:
- Article
Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Pharmacist‐Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization among Patients with Sickle Cell Disease.
- Published in:
- Advances in Hematology, 2024, v. 2024, p. 1, doi. 10.1155/2024/4753349
- By:
- Publication type:
- Article
Enhancing the care of patients with sickle cell disease.
- Published in:
- Nursing Standard, 2019, v. 34, n. 10, p. 29, doi. 10.7748/ns.2019.e11348
- By:
- Publication type:
- Article
Voxelotor Treatment Interferes With Quantitative and Qualitative Hemoglobin Variant Analysis in Multiple Sickle Cell Disease Genotypes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Profound underdosing of β-lactams in patients with sickle-cell disease.
- Published in:
- 2018
- By:
- Publication type:
- Letter
BEHIND THE CURVE.
- Published in:
- Community Practitioner, 2021, v. 94, n. 3, p. 28
- By:
- Publication type:
- Article
Demands and challenges for patients with sickle-cell disease requiring hematopoietic stem cell transplantation in Saudi Arabia.
- Published in:
- Pediatric Transplantation, 2016, v. 20, n. 6, p. 831, doi. 10.1111/petr.12767
- By:
- Publication type:
- Article
Bringing Known Drugs to Pediatric Research: Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.
- Published in:
- American Journal of Bioethics, 2020, v. 20, n. 4, p. 106, doi. 10.1080/15265161.2020.1730485
- By:
- Publication type:
- Article
Bringing Known Drugs to Pediatric Research: Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.
- Published in:
- American Journal of Bioethics, 2020, v. 20, n. 4, p. 106, doi. 10.1080/15265161.2020.1730485
- By:
- Publication type:
- Article
Review.
- Published in:
- Journal of Palliative Medicine, 2013, v. 16, n. 10, p. 1319, doi. 10.1089/jpm.2013.9471
- Publication type:
- Article
The Use of Ketamine in Severe Cases of Refractory Pain Syndromes in the Palliative Care Setting: A Case Series.
- Published in:
- Journal of Palliative Medicine, 2011, v. 14, n. 9, p. 1074, doi. 10.1089/jpm.2010.0424
- By:
- Publication type:
- Article
Factors associated with health-related quality of life in children with sickle cell disease.
- Published in:
- Nursing Children & Young People, 2023, v. 35, n. 4, p. 22, doi. 10.7748/ncyp.2023.e1448
- By:
- Publication type:
- Article
Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients.
- Published in:
- Paediatrics & Child Health (1205-7088), 2019, v. 24, n. 1, p. e45, doi. 10.1093/pch/pxy074
- By:
- Publication type:
- Article
Long-term use of hydroxyurea for sickle cell anemia.
- Published in:
- 2003
- By:
- Publication type:
- commentary
Hydroxyurea: Pattern of Use, Patient Adherence, and Safety Proile in Patients with Sickle Cell Disease in Oman.
- Published in:
- Oman Medical Journal, 2019, v. 34, n. 4, p. 327, doi. 10.5001/omj.2019.64
- By:
- Publication type:
- Article
Folic acid supplementation in children with sickle cell disease: study protocol for a double-blind randomized cross-over trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management of paediatric sickle cell disease pain in Emergency Departments in N.Z.
- Published in:
- Emergency Nurse New Zealand, 2020, p. 6
- By:
- Publication type:
- Article
JOURNAL CLUB. INSIGHT INTO REGULATION OF SWITCH FROM FETAL TO ADULT HEMOGLOBIN.
- Published in:
- Contemporary Pediatrics, 2011, v. 28, n. 11, p. 22
- By:
- Publication type:
- Article
Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review.
- Published in:
- BioMed Research International, 2022, p. 1, doi. 10.1155/2022/2122056
- By:
- Publication type:
- Article
Voxelotor: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 2, p. 209, doi. 10.1007/s40265-020-01262-7
- By:
- Publication type:
- Article
Computer Algorithm‐Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 1, p. 41, doi. 10.1002/jcph.1699
- By:
- Publication type:
- Article
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 298, doi. 10.1002/jcph.598
- By:
- Publication type:
- Article
Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 9, p. 1016, doi. 10.1002/jcph.303
- By:
- Publication type:
- Article
TERAPIA MEDICAMENTOSA NO DOMICÍLIO: EXPERIÊNCIAS DE MÃES DE CRIANÇAS E ADOLESCENTES COM ANEMIA FALCIFORME.
- Published in:
- Cogitare Enfermagem, 2018, v. 23, n. 2, p. 48, doi. 10.5380/ce.v23i2.53462
- By:
- Publication type:
- Article
A Systematic Review of Medication Adherence Interventions in Pediatric Sickle Cell Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cyclic Guanosine Monophosphate-Dependent Protein Kinase I Stimulators and Activators Are Therapeutic Alternatives for Sickle Cell Disease.
- Published in:
- Turkish Journal of Hematology, 2018, v. 35, n. 1, p. 77, doi. 10.4274/tjh.2017.0407
- By:
- Publication type:
- Article
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug Development.
- Published in:
- Journal of Patient Experience, 2023, p. 1, doi. 10.1177/23743735231213767
- By:
- Publication type:
- Article
Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 11, p. 2223, doi. 10.3390/healthcare10112223
- By:
- Publication type:
- Article
Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 8, p. 1506, doi. 10.3390/healthcare10081506
- By:
- Publication type:
- Article
Use of anti-inflammatory analgesics in sickle-cell disease.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2017, v. 42, n. 5, p. 656, doi. 10.1111/jcpt.12592
- By:
- Publication type:
- Article
News From the Food and Drug Administration.
- Published in:
- JAMA: Journal of the American Medical Association, 2017, v. 318, n. 7, p. 604, doi. 10.1001/jama.2017.10130
- By:
- Publication type:
- Article
Sickle cell disease: signs, symptoms and latest treatments: How a new drug will improve quality of life for patients, and could reduce emergency admissions resulting from sickle cell crises.
- Published in:
- Nursing Standard, 2022, v. 37, n. 3, p. 73, doi. 10.7748/ns.37.3.73.s23
- By:
- Publication type:
- Article
Ultrasound-Guided Access for Peripheral Intravenous Therapy.
- Published in:
- MEDSURG Nursing, 2014, p. 1
- By:
- Publication type:
- Article
Voxelotor: A Novel Treatment for Sickle Cell Disease.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 2, p. 240, doi. 10.1177/1060028020943059
- By:
- Publication type:
- Article
Voxelotor.
- Published in:
- American Journal of Health-System Pharmacy, 2020, v. 77, n. 8, p. 598, doi. 10.1093/ajhp/zxaa021
- Publication type:
- Article
Inpatient pain management in sickle cell disease.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 23, p. 1965, doi. 10.1093/ajhp/zxz228
- By:
- Publication type:
- Article
Amino acid product approved for sickle cell disease.
- Published in:
- 2017
- By:
- Publication type:
- Product Review
Adherence to Hydroxyurea Therapy and its Relationship to Clinical Outcomes Among Adults Living With Sickle Cell Disease.
- Published in:
- Hospital Pharmacy, 2024, v. 59, n. 5, p. 507, doi. 10.1177/00185787241238305
- By:
- Publication type:
- Article
Crizanlizumab.
- Published in:
- Hospital Pharmacy, 2023, v. 58, n. 1, p. 23, doi. 10.1177/0018578720925373
- By:
- Publication type:
- Article
Opioid Use in Vaso-Occlusive Crisis During Intravenous Opioid Drug Shortage.
- Published in:
- Hospital Pharmacy, 2022, v. 57, n. 6, p. 721, doi. 10.1177/00185787221095894
- By:
- Publication type:
- Article
Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis.
- Published in:
- Hospital Pharmacy, 2022, v. 57, n. 1, p. 176, doi. 10.1177/0018578721999806
- By:
- Publication type:
- Article
Use of a depression and sleep impairment treatment guideline to improve quality of life for patients with sickle cell disease.
- Published in:
- International Journal of Palliative Nursing, 2018, v. 24, n. 5, p. 246, doi. 10.12968/ijpn.2018.24.5.246
- By:
- Publication type:
- Article